This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar 30;11(4):271.

doi: 10.1038/nrd3706.

Neurodegenerative disease: RXR agonist reverses Alzheimer's disease

Sarah Crunkhorn

PMID: 22460119
DOI: 10.1038/nrd3706

Comment

Neurodegenerative disease: RXR agonist reverses Alzheimer's disease

Sarah Crunkhorn. Nat Rev Drug Discov. 2012.

. 2012 Mar 30;11(4):271.

doi: 10.1038/nrd3706.

Author

Sarah Crunkhorn

PMID: 22460119
DOI: 10.1038/nrd3706

No abstract available

PubMed Disclaimer

Comment on

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE. Cramer PE, et al. Science. 2012 Mar 23;335(6075):1503-6. doi: 10.1126/science.1217697. Epub 2012 Feb 9. Science. 2012. PMID: 22323736 Free PMC article.

References

1. Science. 2012 Mar 23;335(6075):1503-6 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database